Table 1.
Title and Year | Preparation Tested | FMD | PWV | AIx | RHI | Central BP | Microvascular Function | Included in IPD Analysis? |
---|---|---|---|---|---|---|---|---|
Alborzi 200811 | Paricalcitol | X | No | |||||
Sugden 200812 | Vitamin D2 | X | Yes | |||||
Witham 201013 | Vitamin D3 | X | Yes | |||||
Harris 201114 | Vitamin D3 | X | Yes | |||||
Gepner 201215 | Vitamin D3 | X | X | X | X | Yes | ||
Larsen 201216 | Vitamin D3 | X | X | X | Yes | |||
Marckmann 201217 | Vitamin D3 | X | X | X | Yes | |||
Sokol 201218 | Vitamin D2 | X | Yes | |||||
Stricker 201219 | Vitamin D3 | X | X | X | Yes | |||
Witham 201220 | Vitamin D2 | X | Yes | |||||
Breslavsky 201321 | Vitamin D3 | X | Yes | |||||
Hewitt 201322 | Vitamin D3 | X | No | |||||
Witham 201323 | Vitamin D3 | X | X | Yes | ||||
Witham 201324 | Vitamin D3 | X | Yes | |||||
Witham 201325 | Vitamin D3 | X | X | X | X | X | Yes | |
Yiu 201326 | Vitamin D3 | X | X | No | ||||
Dreyer 201427 | Vitamin D2 | X | X | Yes | ||||
Martins 201428 | Vitamin D3 | X | No | |||||
Mose 201429 | Vitamin D3 | X | X | X | Yes | |||
Ryu 201430 | Vitamin D3 | X | X | No | ||||
Zoccali 201431 | Paricalcitol | X | Yes | |||||
Garg 201532 | Vitamin D3 | X | X | Yes | ||||
Pilz 201533 | Vitamin D3 | X | Yes | |||||
Thethi 201534 | Paricalcitol | X | No | |||||
Witham 201535 | Vitamin D3 | X | X | X | Yes | |||
Barchetta 201636 | Vitamin D3 | X | Yes | |||||
Borgi 201737 | Vitamin D2 | X | No | |||||
Bressendorff 201638 | Vitamin D3 | X | X | X | Yes | |||
Dalan 201639 | Vitamin D3 | X | X | Yes | ||||
Forouhi 201640 |
Vitamin D2 Vitamin D3 |
X | Yes | |||||
Hin 201741 | Vitamin D3 | X | X | Yes |
AIx indicates augmentation index; BP, blood pressure; FMD, flow‐mediated dilatation of the brachial artery; IPD, individual participant data; PWV, pulse wave velocity; RHI, reactive hyperemia index.